A Live Baby or Your Money Back: The Marketing of In Vitro Fertilization Procedures

References

• Alsalili M., Yuzpe A., Tummon I., Parker J., Martin J., Daniel S., Rebel M., Nisker J. Cumulative pregnancy rates and pregnancy outcomes after in-vitro fertilization: >5000 cycles at one centre. Human Reproduction (1995) 10:470–474Google Scholar
• Check J. H., Baker A., Lurie D., Benfer K., Callan C. Comparison of the cumulative probability of pregnancy after in vitro fertilization—Embryo transfer by infertility factor and age. Fertility Sterility (1994) 61:257–261Google Scholar
• Crowder M. J. Beta-binomial ANOVA for proportions. Appl. Statist. (1978) 27(1):34–37Crossref, Google Scholar
• Davis K. The agonizing price of infertility. Kiplinger Online (1996) 1–7(May) www.kiplinger.comGoogle Scholar
• Dawood M. Y. In vitro fertilization, gamete intrafallopian transfer, and superovulation with intrauterine insemination: Efficacy and potential health hazards on babies delivered. Amer. J. Obstetrics Gynecology (1996) 174:1208–1217Crossref, Google Scholar
• Diczfalusy E., Crosignani P. G. Introduction: From reproductive endocrinology to reproductive health. Human Reproduction (1996) 11:1776–1777Crossref, Google Scholar
• European Society for Human Reproduction and Embryology (ESHRE) Capri Workshop Infertility revisited: The state of the art today and tomorrow. Human Reproduction (1996) 11:1779–1807Crossref, Google Scholar
• Freudenheim M. Aetna is reducing fertility benefits: Advanced treatment coverage is eliminated by a pioneer. The New York Times (1998) A1–A11January 10Google Scholar
• Friedler S., Mashiach S., Laufer N. Births in Israel resulting from in-vitro fertilization/embryo transfer, 1982–1989: National Registry of the Israeli Association for Fertility Research. Human Reproduction (1992) 7:1159–1163Google Scholar
• Gleicher N., VanderLaan B., Pratt D., Karande V. Background pregnancy rates in an infertile population. Human Reproduction (1996) 11:1011–1012Crossref, Google Scholar
• Golombok S. Psychological functioning in infertility patients. Human Reproduction (1992) 7:208–212Crossref, Google Scholar
• Greene J. D.Consumer Behavior Models for Non-Statisticians (1982) (Praeger, New York) Google Scholar
• Griffiths D. A. Maximum likelihood estimation for the beta-binomial distribution and an application to the household distribution of the total number of cases of a disease. Biometrics (1973) 29:637–648Crossref, Google Scholar
• Haan G., Rutten F. No cure, no pay: An acceptable way of financing fertility treatments. Health Policy (1989) 13:239–249Crossref, Google Scholar
• Haan G., van Steen R. Costs in relation to effects of in-vitro fertilization. Human Reproduction (1992) 7:982–986Google Scholar
• Haan G., Bernardus R. E., Hollanders J. M. G., Leerentveld B. A., Prak F. M., Naaktgeboren N. Results of IVF from a prospective multicentre study. Human Reproduction (1991a) 6:805–810Google Scholar
• Haan G., Bernardus R. E., Hollanders J. M. G., Leerentveld B. A., Prak F. M., Naaktgeboren N. Selective drop-out in successive in-vitro fertilization attempts: The pendulum danger. Human Reproduction (1991b) 6:939–943Google Scholar
• Hershlag A., DeCherney A. H., Kaplan E. H., Lavy G., Loy R. A. Heterogeneity in patient populations explains differences in in vitro fertilization programs. Fertility Sterility (1991) 56:913–917Google Scholar
• Hull M. G. R. Infertility treatment: Relative effectiveness of conventional and assisted conception methods. Human Reproduction (1992) 7:785–796Google Scholar
• Hyman D. A., Silver C. Letter to the editor. J. Law, Medicine Ethics (1998) 26(1):94–95Google Scholar
• Johnson N. L., Kotz S.Continuous Univariate Distributions (1970) 2(John Wiley and Sons, New York) Google Scholar
• Maritz J. S.Empirical Bayes Methods (1970) (Methuen, London, U.K) Google Scholar
• Murray T. H. Money-back guarantees for IVF: An ethical critique. J. Law, Medicine Ethics (1997) 25:292–294Crossref, Google Scholar
• Norris F. The many lives made miserable by a low-down high-roller. The New York Times (1997) E7March 9Google Scholar
• RESOLVERESOLVE National Newsletter (1997) 22(1Google Scholar
• Robertson J. A., Schneyer T. J. Professional self-regulation and shared-risk programs for in vitro fertilization. J. Law, Medicine Ethics (1997) 25:283–291Crossref, Google Scholar
• Rubin A. J., Zitner A. Infertility cases spur an illicit drug market. Los Angeles Times (2000) (September 10)):A20Google Scholar
• Schmittlein D. C. Surprising inferences from unsurprising observations: Do conditional expectations really regress to the mean. Amer. Statist. (1989) 43(3):176–183Crossref, Google Scholar
• Society for Assisted Reproductive Technology and The American Society for Reproductive Medicine Assisted reproductive technology in the United States and Canada: 1994 results generated from the American Society for Reproductive Medicine/Society for Assisted Reproductive Technology Registry. Fertility Sterility (1996a) 66:697–705Google Scholar
• Society for Assisted Reproductive Technology and The American Society for Reproductive Medicine Clinic specific report for 1994. (1996b) (Society for Assisted Reproductive Technology and the American Society for Reproductive Medicine, Birmingham, AL) Google Scholar
• Stolberg S. G. For the infertile, a high-tech treadmill. The New York Times (1997) 1–36(December 14)Google Scholar
• Stolwijk A. M., Hamilton C. J. C. M., Hollanders J. M. G., Bastiaans L. A., Zielhuis G. A. A more realistic approach to the cumulative pregnancy rate after in-vitro fertilization. Human Reproduction (1996) 11:660–663Crossref, Google Scholar
• Strictly BusinessThe Newshour with Jim Lehrer (1997) (Overland Park, KS) . (January 27)Google Scholar
• Tan S.-L., Doyle P., Maconochie N., Edwards R. G., Baken A., Bekir J., Brinsden P., Campbell S. Pregnancy and birth rates of live infants after in vitro fertilization in women with and without previous in vitro fertilization pregnancies: A study of eight thousand cycles at one center. Amer. J. Obstetrics Gynecology (1994a) 170:34–40Crossref, Google Scholar
• Tan S.-L., Maconochie N., Doyle P., Campbell S., Balen A., Bekir J., Brinsden P., Edwards R. G., Jacobs H. S. Cumulative conception and live-birth rates after in vitro fertilization with and without the use of long, short, and ultrashort regimens of the gonadotropin-releasing hormone agonist buserelin. Amer. J. Obstetrics Gynecology (1994b) 171:513–520Crossref, Google Scholar
• Thaler R. H., Johnson E. J. Gambling with the house money and trying to break even: The effects of prior outcomes on risky choice. Management Sci. (1990) 36:643–660Link, Google Scholar
• Trafford A. Medicine's money back warranty. The Washington Post (1997) Z06(August 5)Google Scholar
• U.S. Centers for Disease Control and Prevention 1996 assisted reproductive technology success rates national summary and fertility clinic reports. (2002a) . http://www.cdc.gov/nccdphp/drh/art96/Google Scholar
• U.S. Centers for Disease Control and Prevention 1999 assisted reproductive technology success rates national summary and fertility clinic reports. (2002b) . http://www.cdc.gov/nccdphp/drh/art99/Google Scholar
• Wagner M., Clair P. St. Are in-vitro fertilization and embryo transfer of benefit to all. Lancet (1989) ii:1027–1030Crossref, Google Scholar
• Yovel I., Geva E., Lessing J. B., Yaron Y., Botchan A., Amit A. Analysis of the fourth to eighth in-vitro fertilization treatments after three previously failed attempts. Human Reproduction (1994) 9:738–741Google Scholar
• Zhou H., Weinberg C. R., Wilcox A. J., Baird D. D. A random-effects model for cycle viability in fertility studies. J. Amer. Statist. Assoc. (1996) 91:1413–1422Crossref, Google Scholar